CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis

The comprehension of the pathogenesis of Trypanosoma cruzi-elicited myocarditis is crucial to delineate new therapeutic strategies aiming to ameliorate the inflammation that leads to heart dysfunction, without hampering parasite control. The augmented expression of CCL5/RANTES and CCL3/MIP-1alpha, and their receptor CCR5, in the heart of T. cruzi-infected mice suggests a role for CC-chemokines and their receptors in the pathogenesis of T. cruzi-elicited myocarditis. Herein, we discuss our recent results using a CC-chemokine receptor inhibitor (Met-RANTES), showing the participation of CC-chemokines in T. cruzi infection and unraveling CC-chemokine receptors as an attractive therapeutic target for further evaluation in Chagas disease.

Saved in:
Bibliographic Details
Main Authors: Marino,APMP, Silva,AA, Santos,PVA, Pinto,LMO, Gazinelli,RT, Teixeira,MM, Lannes-Vieira,J
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2005
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762005000900015
Tags: Add Tag
No Tags, Be the first to tag this record!